8.5亿元首付款,深圳卖了一个体内CAR-T

动脉新医药
Oct 21, 2025

近日,深圳普瑞金生物技术股份有限公司(Pregene,下称“普瑞金”)宣布,与美国生物制药公司吉利德科学(Gilead Sciences,下称“吉利德”)旗下的Kite Pharma达成战略合作协议,双方将围绕体内嵌合抗原受体T细胞疗法(in vivo CAR-T,Chimeric Antigen Receptor T-cell)开展联合研发。根据声明,本次合作总金额最高可达16.4亿美元,包括...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10